India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity sharehol...
Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy&...
Eisai Co. and Biogen Inc. have announced that LEQEMBI® Pen, the subcutaneous (SC) formulation of the anti-amyloid be...
Ask anyone who negotiates drug licences for a living what changed in the last two years, and you will usually get the sa...
Shilpa Biologicals, an India-based integrated biologics development and manufacturing organisation, has announced an exc...
The Ministry of Health and Welfare (MOHW), South Korea government, has announced the launch of the Public-Private Pharma...
GSK plc has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Bio...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pe...
BioSpectrum Asia has published The CEO Handbook 2026, a seventy two page Career Spotlight edition profiling fifty chief ...
Japan-based Shionogi has received marketing authorisation from the Therapeutic Goods Administration (TGA) in Australia f...
ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complic...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Singapore is expanding subsidised access to Roche’s Columvi, or glofitamab, for eligible patients with relapsed or...
Before we discuss the market, can you tell us about your role and what drew you to this area of healthcare logistics? I...
For years, sustainability in pharmaceuticals was largely discussed in terms of commitments, targets and disclosures. Tha...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (...
Biopharmaceutical manufacturing is entering a period of significant change. With over 2000 biological therapeutics in de...
Rare diseases/orphan diseases affect a very small fraction of the population and are frequently debilitating. World Heal...
US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...
